학술논문
A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variants.
Document Type
Article
Author
Source
Signal Transduction & Targeted Therapy; 3/16/2023, p1-13, 13p
Subject
Language
ISSN
20959907